ICM
TBI

Invenomic Capital Management’s Trueblue TBI Stock Holding History

Invenomic Capital Management’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Sell
318,771
-90,665
-22% -$505K 0.13% 100
2026
Q1 		$1.6M Sell
409,436
-32,789
-7% -$146K 0.07% 132
2025
Q4 		$2.01M Buy
442,225
+166,660
+60% +$855K 0.09% 133
2025
Q3 		$1.69M Sell
275,565
-14,728
-5% -$93.2K 0.08% 137
2025
Q2 		$1.88M Sell
290,293
-35,969
-11% -$194K 0.11% 137
2025
Q1 		$1.73M Sell
326,262
-15,121
-4% -$103K 0.09% 156
2024
Q4 		$2.87M Buy
341,383
+106,736
+45% +$824K 0.14% 134
2024
Q3 		$1.85M Sell
234,647
-45,301
-16% -$408K 0.1% 137
2024
Q2 		$2.88M Buy
279,948
+155,611
+125% +$1.69M 0.14% 132
2024
Q1 		$1.56M Buy
+124,337
New +$1.61M 0.08% 132
2022
Q3 		– Sell
-347,569
Closed -$6.22M – 192
2022
Q2 		$6.22M Buy
347,569
+69,561
+25% +$1.63M 0.44% 67
2022
Q1 		$6.46M Buy
278,008
+27,067
+11% +$744K 0.69% 44
2021
Q4 		$6.94M Buy
250,941
+72,038
+40% +$2.04M 1.48% 18
2021
Q3 		$4.84M Buy
178,903
+76,565
+75% +$2.05M 1.57% 20
2021
Q2 		$2.88M Buy
102,338
+80,966
+379% +$2.16M 0.69% 34
2021
Q1 		$471K Buy
21,372
+1,814
+9% +$37.2K 0.11% 100
2020
Q4 		$365K Buy
+19,558
New +$352K 0.09% 108

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IH
IES Holdings Houston, Texas $311M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invenomic Capital Management's TBI Position: Q2 2026 in Review

Invenomic Capital Management reduced its Trueblue (TBI) stake by 22% in Q2 2026, selling an estimated $505K and leaving 318,771 shares worth $2.22M. The position accounts for 0.13% of the portfolio, ranked #100.

Invenomic Capital Management first reported a position in TBI in Q4 2020 and has held it in 17 quarters since. The position peaked at $6.94M in Q4 2021. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Invenomic Capital Management held 318,771 shares of Trueblue worth $2.22M as of Q2 2026.
  • Invenomic Capital Management sold 90,665 Trueblue shares in Q2 2026, an estimated $505K.
  • Trueblue made up 0.13% of Invenomic Capital Management's portfolio in Q2 2026, its #100 holding.
  • Invenomic Capital Management first reported a position in Trueblue in Q4 2020 and has held it in 17 quarters since.
  • Invenomic Capital Management's Trueblue position peaked at $6.94M in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.